Concepedia

Manjola Balliu

MB

14

Publications

322

Citations

12

H-Index

2009

Active since

Affiliations

University of Florence(Current)

University of Modena and Reggio Emilia

Azienda Ospedaliero-Universitaria Careggi

Azienda Ospedaliero-Universitaria di Modena

Ferrari (Italy)

Manjola Balliu is an author at University of Florence specializing in medicine, cell biology, and cell death.

ORCID

Top concepts

Publications per year

2009–2024

14

Publications

14

Calreticulin Ins5 and Del52 mutations impair unfolded protein and oxidative stress responses in K562 cells expressing CALR mutants

Simona Salati, Elena Genovese, Chiara Carretta et al. · Scientific Reports · 2019 · 63 citations · Full text

Inhibitors of the PI3K/mTOR pathway prevent STAT5 phosphorylation in<i>JAK2V617F</i>mutated cells through PP2A/CIP2A axis

Niccolò Bartalucci, Laura Calabresi, Manjola Balliu et al. · Oncotarget · 2017 · 37 citations · Full text

RETRACTED: <scp>HDAC</scp> ‐inhibitor (S)‐8 disrupts <scp>HDAC</scp> 6‐ <scp>PP</scp> 1 complex prompting A375 melanoma cell growth arrest and apoptosis

Manjola Balliu, Luca Guandalini, María Novella Romanelli et al. · Journal of Cellular and Molecular Medicine · 2014 · 30 citations · Full text

Effectiveness of the Histone Deacetylase Inhibitor (S)-2 against LNCaP and PC3 Human Prostate Cancer Cells

Anna Laurenzana, Manjola Balliu, Cristina Cellai et al. · PLoS ONE · 2013 · 29 citations · Full text

, , +19

Clinical impact of mutated <scp>JAK2</scp> allele burden reduction in polycythemia vera and essential thrombocythemia

Paola Guglielmelli, Barbara Mora, Francesca Gesullo et al. · American Journal of Hematology · 2024 · 23 citations · Full text

Rows per page

1–5 of 14